SK282977B6 - Tiolové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Tiolové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK282977B6
SK282977B6 SK889-98A SK88998A SK282977B6 SK 282977 B6 SK282977 B6 SK 282977B6 SK 88998 A SK88998 A SK 88998A SK 282977 B6 SK282977 B6 SK 282977B6
Authority
SK
Slovakia
Prior art keywords
phenylalanine
mercapto
phenylmethylpropionyl
group
thiazolyl
Prior art date
Application number
SK889-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK88998A3 (en
Inventor
Franco Pellacini
Mario Fantucci
Gabriele Norcini
Stefano Romagnano
Francesco Santangelo
Claudio Semeraro
Original Assignee
Zambon Group S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group S. P. A. filed Critical Zambon Group S. P. A.
Publication of SK88998A3 publication Critical patent/SK88998A3/sk
Publication of SK282977B6 publication Critical patent/SK282977B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Treatment Of Fiber Materials (AREA)
  • Preliminary Treatment Of Fibers (AREA)
SK889-98A 1995-12-28 1996-12-17 Tiolové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie SK282977B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI002773A IT1277737B1 (it) 1995-12-28 1995-12-28 Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
PCT/EP1996/005663 WO1997024342A1 (en) 1995-12-28 1996-12-17 Thiol derivatives with metallopeptidase inhibitory activity

Publications (2)

Publication Number Publication Date
SK88998A3 SK88998A3 (en) 1998-12-02
SK282977B6 true SK282977B6 (sk) 2003-01-09

Family

ID=11372827

Family Applications (1)

Application Number Title Priority Date Filing Date
SK889-98A SK282977B6 (sk) 1995-12-28 1996-12-17 Tiolové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (30)

Country Link
EP (1) EP0877740B1 (de)
JP (1) JP2000502687A (de)
KR (1) KR19990076809A (de)
CN (1) CN1071325C (de)
AP (1) AP1186A (de)
AR (1) AR004413A1 (de)
AT (1) ATE292123T1 (de)
AU (1) AU713156B2 (de)
BG (1) BG63942B1 (de)
BR (1) BR9612373A (de)
CA (1) CA2241414A1 (de)
CZ (1) CZ204698A3 (de)
DE (1) DE69634543D1 (de)
EA (1) EA000991B1 (de)
EE (1) EE03766B1 (de)
GE (1) GEP19991871B (de)
IL (1) IL124915A (de)
IS (1) IS1885B (de)
IT (1) IT1277737B1 (de)
NO (1) NO310914B1 (de)
NZ (1) NZ325785A (de)
OA (1) OA10704A (de)
PL (1) PL188151B1 (de)
RO (1) RO119882B1 (de)
SK (1) SK282977B6 (de)
TR (1) TR199801229T2 (de)
UA (1) UA62923C2 (de)
UY (1) UY24425A1 (de)
WO (1) WO1997024342A1 (de)
ZA (1) ZA9610891B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289522B1 (it) * 1996-12-24 1998-10-15 Zambon Spa Processo per la preparazione di eteroaril-fenilalanine
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
GB0203665D0 (en) * 2002-02-15 2002-04-03 Glaxo Group Ltd Process
MY140707A (en) 2002-02-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Process for preparing a phenylalanine derivative and intermediates thereof
WO2003074478A1 (en) 2002-03-05 2003-09-12 Sumitomo Chemical Company, Limited Process for the preparation of biaryl compounds
AU2003232941A1 (en) * 2002-06-07 2003-12-22 Glaxo Group Limited N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
GB0213122D0 (en) * 2002-06-07 2002-07-17 Glaxo Group Ltd Compounds
US7045653B2 (en) 2002-12-23 2006-05-16 Pfizer, Inc. Pharmaceuticals
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
RU2426532C2 (ru) 2004-03-17 2011-08-20 Новартис Аг Применение органических соединений
WO2010112050A1 (en) 2009-04-03 2010-10-07 Statoil Asa Equipment and method for reinforcing a borehole of a well while drilling
JP2013518897A (ja) * 2010-02-03 2013-05-23 エムイーエイチ アソシエイツ,インコーポレイテッド 選択的および生体活性的等配電子体としての多重置換フルオロメタン
WO2011116115A1 (en) 2010-03-16 2011-09-22 Novartis Ag Aliskiren composition comprising a medium chain fatty acid, their process of manufacturing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
FR2652087B1 (fr) * 1989-09-15 1993-10-15 Bioprojet Ste Civile Derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques.
FR2682952B1 (fr) * 1991-10-25 1993-12-03 Institut Nal Sante Recherc Medic Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.
IT1273455B (it) * 1995-01-27 1997-07-08 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi

Also Published As

Publication number Publication date
CN1071325C (zh) 2001-09-19
KR19990076809A (ko) 1999-10-15
PL188151B1 (pl) 2004-12-31
NO310914B1 (no) 2001-09-17
UY24425A1 (es) 1997-01-09
PL327580A1 (en) 1998-12-21
SK88998A3 (en) 1998-12-02
IS1885B (is) 2003-08-15
BR9612373A (pt) 1999-07-13
IS4780A (is) 1998-06-22
ITMI952773A1 (it) 1997-06-28
NZ325785A (en) 1999-09-29
AU713156B2 (en) 1999-11-25
BG102553A (en) 1999-04-30
EE9800192A (et) 1998-12-15
CZ204698A3 (cs) 1998-11-11
EP0877740B1 (de) 2005-03-30
AR004413A1 (es) 1998-11-04
EA199800544A1 (ru) 1999-02-25
EP0877740A1 (de) 1998-11-18
ITMI952773A0 (de) 1995-12-28
IT1277737B1 (it) 1997-11-12
NO982977D0 (no) 1998-06-26
RO119882B1 (ro) 2005-05-30
HK1018008A1 (en) 1999-12-10
AP9801264A0 (en) 1998-06-30
GEP19991871B (en) 1999-12-06
IL124915A (en) 2001-10-31
CA2241414A1 (en) 1997-07-10
EE03766B1 (et) 2002-06-17
NO982977L (no) 1998-08-27
JP2000502687A (ja) 2000-03-07
WO1997024342A1 (en) 1997-07-10
ZA9610891B (en) 1997-06-27
CN1206411A (zh) 1999-01-27
DE69634543D1 (de) 2005-05-04
EA000991B1 (ru) 2000-08-28
UA62923C2 (en) 2004-01-15
IL124915A0 (en) 1999-01-26
BG63942B1 (bg) 2003-07-31
AP1186A (en) 2003-07-07
TR199801229T2 (xx) 1998-09-21
AU1301897A (en) 1997-07-28
OA10704A (en) 2002-11-28
ATE292123T1 (de) 2005-04-15

Similar Documents

Publication Publication Date Title
EP0877740B1 (de) Thiol-derivative mit metallopeptidase hemmender wirkung
DE69923676T2 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
KR19990087484A (ko) 아미드 결합을 포함하는 신규의 황 유도체, 그의 제조방법,약물로서 그의 용도, 및 그를 함유하는 제약 조성물
EP0636621B1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
US5994539A (en) Mercapto acyl aminoacid derivatives endowed with dual ACE-NEP inhibitory activity, useful in the treatment of cardiovascular diseases
DE69614508T2 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
US6548480B1 (en) Phosphonic acid derivatives with metallopeptidase inhibitory activity
EP0883612B1 (de) Mercapto derivate mit metallopeptidase(ace/nep) inhibiernder wirkung
HUP9903636A2 (hu) Metallopeptidáz-gátló hatású tiolszármazékok, eljárás azok előállítására, ilyen tiolszármazékokat tartalmazó gyógyszerkészítmények és eljárás azok alkalmazására
WO1992008713A1 (en) N-[(2-thenoylmercapto-3-methyl)-butanoyl]-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it